Home › Funds › ACT CAPITAL MANAGEMENT, LLC › VKTX

ACT CAPITAL MANAGEMENT, LLC position in VKTX

VIKING THERAPEUTICS INC · Health Care

ACT CAPITAL MANAGEMENT, LLC reported holding 209,300 shares of VKTX (VIKING THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$8.2M, representing 5.33% of its reported portfolio and ranking #7 among its reported holdings. ACT CAPITAL MANAGEMENT, LLC has disclosed VKTX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)209.30K sh
Reported value held$8.16M
Portfolio Weight5.33%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ACT CAPITAL MANAGEMENT, LLC's VKTX position evolved

ACT CAPITAL MANAGEMENT, LLC first disclosed a stake in VKTX in Q4 2025 at 206,100 shares (US$7.3M). The position peaked in Q2 2026 at 209,300 shares, worth US$8.2M. Across 3 filings, ACT CAPITAL MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 209,300 shares valued at US$8.2M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 206.10K $7.25M New
Q1 2026 209.30K $6.81M Add
Q2 2026 209.30K $8.16M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VKTX and 13F data

VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in VKTX — the largest reported positions include Vestal Point Capital, LP (US$26.5M), Eversept Partners, LP (US$23.5M), ADAR1 Capital Management, LLC (US$22.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VKTX

All VKTX fund holders →

FAQ

How long has ACT CAPITAL MANAGEMENT, LLC held VKTX?

ACT CAPITAL MANAGEMENT, LLC has disclosed VKTX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is ACT CAPITAL MANAGEMENT, LLC's current position in VKTX?

As of Q2 2026, ACT CAPITAL MANAGEMENT, LLC holds 209.30K shares of VKTX (VIKING THERAPEUTICS INC), valued at $8.16M, representing 5.33% of its reported portfolio and ranking #7.

Has ACT CAPITAL MANAGEMENT, LLC been buying or selling VKTX?

In the latest 13F filing (Q2 2026), ACT CAPITAL MANAGEMENT, LLC held unchanged its position in VKTX. The position peaked in Q2 2026 at 209.30K shares.

Which other funds hold VKTX?

Other major institutional holders of VKTX include Vestal Point Capital, LP, Eversept Partners, LP, ADAR1 Capital Management, LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.